Filing Details
- Accession Number:
- 0000899243-23-018119
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-14 17:13:45
- Reporting Period:
- 2023-08-11
- Accepted Time:
- 2023-08-14 17:13:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1808898 | Benitec Biopharma Inc. | BNTC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1808923 | Megan Boston | C/O Benitec Biopharma Inc. 3940 Trust Way Hayward CA 94545 | Executive Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-11 | 25,907 | $0.00 | 25,907 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Warrants (right to buy) | Acquisiton | 2023-08-11 | 25,907 | $0.00 | 25,907 | $3.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,907 | 2023-08-11 | 2028-08-11 | No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 20 | Indirect | By Boston Super Invest Pty A/C Boston Family Super |
Footnotes
- Represents shares of common stock, par value $0.0001 per share (the "Common Stock") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93.
- The reported number of shares has been adjusted to reflect the impact of the Issuer's 17-for-1 reverse stock split completed on July 26, 2023.
Billionaire Hedge Funds
